🔗 Permalink

Assignee profile:

Shionogi Co., Ltd.

City:

Osaka

Country:

Japan

Published Applications:

425

Last publication date:

2026-06-25

Patent Grants:

340

Last grant date:

2026-02-10

Quarterly Shionogi Co., Ltd. Patent Applications

Top Inventors for applications by Shionogi Co., Ltd.

These are the the leading inventors for applications assigned to Shionogi Co., Ltd.:

Yoshiyuki TAODA 51 Osaka, Japan
Takashi KAWASUJI 35 Osaka, Japan
Teruhiko TAISHI 24 Osaka, Japan
Toshiyuki Akiyama 20 Osaka, Japan

Makoto Kawai 19 Osaka, Japan
Brian A. JOHNS 19 Research Triangle Park, NC United States
Brian Alvin Johns 18 Research Triangle Park, NC United States
Kenji Tomita 16 Osaka, Japan

Hidenori MIKAMIYAMA 16 Osaka, Japan
Akira Yukimasa 15 Osaka, Japan
Hiroyuki KAI 15 Osaka, Japan
Masayoshi MIYAGAWA 14 Osaka, Japan

Shinji Suzuki 13 Osaka, Japan
Koji MASUDA 13 Osaka, Japan
Yukio TADA 13 Osaka, Japan
Tomoyuki Ogawa 12 Osaka, Japan

Akihiro Hori 12 Osaka, Japan
Yasuhiko Kanda 12 Osaka, Japan
Hiroshi YOSHIDA 11 Osaka, Japan
Naotake Kobayashi 11 Osaka, Japan

Masanao INAGAKI 11 Osaka, Japan
Yuuji Kooriyama 10 Osaka, Japan
Akira Kugimiya 10 Osaka, Japan
Azusa OKANO 10 Osaka, Japan

Jason Gordon WEATHERHEAD 10 Research Triangle Park, NC United States
Yasunori AOYAMA 10 Osaka, Japan
Yoshinori TAMURA 9 Osaka, Japan
Moriyasu Masui 8 Osaka, Japan

Kohji HANASAKI 8 Osaka, Japan
Yuto UNOH 8 Osaka, Japan
Noriyuki Kurose 8 Osaka, Japan
Yuki TACHIBANA 8 Osaka, Japan

Naoki Ohyabu 8 Osaka, Japan
Toshikazu HAKOGI 8 Osaka, Japan
Takatsugu INOUE 8 Osaka, Japan
Naoyuki Suzuki 8 Osaka, Japan

Yuji NISHIURA 8 Osaka, Japan
Yoshiharu HIRAMATSU 8 Osaka, Japan
Kenji Nakahara 7 Osaka, Japan
Masami TAKAYAMA 7 Osaka, Japan

Kosuke ANAN 7 Osaka, Japan
Natsuki ISHIZUKA 7 Osaka, Japan
Ken Yasui 7 Osaka, Japan
Shuji Yonezawa 7 Osaka, Japan

Yuusuke Tamura 7 Osaka, Japan
Kazuo Ueda 7 Osaka, Japan
Yoshikazu SASAKI 7 Osaka, Japan
Keiichiro HIRAI 6 Osaka, Japan

Kana KURAHASHI 6 Osaka, Japan
Yusuke TATENO 6 Osaka, Japan
Gaku Sakaguchi 6 Shiga, Japan
Shinji SUZUKI 6 Osaka-shi, Japan

Kenji Yamawaki 6 Toyonaka, Japan
Eiichi Kojima 6 Osaka, Japan
Mitsuaki Ohtani 6 Nara, Japan
Kouhei NODU 6 Osaka, Japan

Tsuyoshi Hasegawa 6 Osaka, Japan
Tatsuhiko Ueno 6 Osaka, Japan
Shionogi & Co., Ltd. 6 Osaka, Japan
Kenji Yamawaki 6 Toyonaka-shi, Japan

Satoru TANAKA 6 Osaka, Japan
Kenichiroh NAKAMURA 6 Osaka, Japan
Sae Matsumoto 6 Osaka, Japan
Junji Onoda 6 Toyonaka-shi, Japan

Shoji Yamane 6 Toyonaka-shi, Japan
Masanao Inagaki 6 Toyonaka-shi, Japan
Tohru HORIGUCHI 6 Osaka, Japan
Takami MURASHI 6 Osaka, Japan

Shota UEHARA 6 Osaka, Japan
Kazuya KANO 6 Osaka, Japan
Masaaki Uenaka 5 Osaka, Japan
Kenji Morimoto 5 Osaka, Japan

Susumu MITSUMORI 5 Osaka, Japan
Manabu Katou 5 Osaka, Japan
Hiroyuki TOBINAGA 5 Osaka, Japan
Toshihiro WADA 5 Osaka, Japan

Yuji Koriyama 5 Osaka, Japan
Hitoshi MURAI 5 Osaka, Japan
Toshio FUJISHITA 5 Osaka, Japan
Masahiko Fujioka 5 Osaka, Japan

Akira Kato 5 Shiga, Japan
Hidekazu Haraguchi 5 Osaka, Japan
Daiki NAGAMATSU 5 Osaka, Japan
Chika TAKAHASHI 5 Osaka, Japan

Kenji Takaya 5 Osaka, Japan
Junji Onoda 5 Toyonaka, Japan
Chiaki FUJIKOSHI 5 Osaka, Japan
Yasuhiko FUJII 5 Osaka, Japan

Nobuhiro Haga 5 Toyonaka-shi, Japan
Hiroki Yamaguchi 5 Osaka, Japan
Shoji Yamane 5 Toyonaka, Japan
Motohiro FUJIU 5 Osaka, Japan

Yoshinori Tamura 5 Toyonaka-shi, Japan
Tatsuya Takahashi 5 Toyonaka, Japan
Laykea Tafesse 5 Robbinsville, NJ United States
Masanao Inagaki 5 Toyonaka, Japan

Yasuyuki KAWANISHI 4 Amagasaki-Shi, Japan
Shoichi Naito 4 Toyonaka, Japan
Yutaka TOMIDA 4 Osaka, Japan
Toshiaki Aoki 4 Toyonaka-shi, Japan

Recent patent applications by Shionogi Co., Ltd.

Shionogi Co., Ltd. based in Osaka, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-06-25

US20260174775A1

Human necessities

PROPHYLACTIC AND THERAPEUTIC PHARMACEUTICAL AGENT FOR HIV INFECTIOUS DISEASES CHARACTERIZED BY COMPRISING COMBINATION OF INTEGRASE INHIBITOR AND ANTI-HIV AGENT

#2 | 2026-06-11

US20260157927A1

Human necessities

METHOD FOR IMPROVING ATTENTION FUNCTION OF A SUBJECT, METHOD FOR IMPROVING FLUENCY OF A SUBJECT, AND METHOD FOR IMPROVING CONGNITIVE FUNCTION OF A SUBJECT

#3 | 2026-05-28

US20260144802A1

Human necessities

POST-OPERATIVE DELIRIUM SUPPRESSANT

#4 | 2026-05-07

US20260125392A1

Chemistry; metallurgy

URACIL DERIVATIVES HAVING VIRUS REPLICATION INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

#5 | 2026-05-07

US20260125365A1

Chemistry; metallurgy

TRIAZINE DERIVATIVES HAVING VIRUS REPLICATION INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

#6 | 2026-04-09

US20260098031A1

Chemistry; metallurgy

MONOCYCLIC COMPOUND HAVING GLP-1 RECEPTOR AGONIST ACTIVITY

#7 | 2026-04-09

US20260097037A1

Human necessities

FUSED RING COMPOUND HAVING GLP-1 RECEPTOR AGONIST EFFECT

#8 | 2026-04-02

US20260091022A1

Human necessities

PHARMACEUTICAL COMPOSITION FOR TREATING FATTY LIVER DISEASE

#9 | 2025-10-23

US20250326836A1

Chemistry; metallurgy

ANTIBODY THAT BINDS TO CANNABINOID TYPE 1 RECEPTORS

#10 | 2025-08-14

US20250257072A1

Chemistry; metallurgy

PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUG THEREOF

#11 | 2025-04-24

US20250127788A1

Human necessities

PHARMACEUTICAL COMPOSITION CONTAINING TRIAZINE DERIVATIVE

#12 | 2025-03-27

US20250099474A1

Human necessities

PHARMACEUTICAL FOR TREATMENT OF NOVEL CORONAVIRUS INFECTION

#13 | 2025-03-20 ✅ Patent 12,545,687 granted on 2026-02-10

US20250092056A1

Chemistry; metallurgy

URACIL DERIVATIVES HAVING VIRUS REPLICATION INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

#14 | 2025-03-20

US20250090048A1

Human necessities

SYSTEM, METHOD, AND NON-TRANSITORY COMPUTER-READABLE RECORDING MEDIUM

#15 | 2025-03-06

US20250073226A1

Human necessities

USE OF OPIOID FOR TREATMENT OF AUTISM SPECTRUM DISORDERS

#16 | 2025-02-06

US20250041279A1

Human necessities

THERAPEUTIC MEDICINE FOR HEART DISEASE OR SKELETAL MUSCLE DISEASE

#17 | 2025-01-23

US20250025459A1

Human necessities

COVID-19 TREATMENT MEDICINE CHARACTERIZED BY COMBINING 3CL PROTEASE INHIBITOR AND COVID-19 TREATMENT DRUG

#18 | 2024-12-05

US20240400560A1

Chemistry; metallurgy

BICYCLIC HETEROCYCLIC DERIVATIVE HAVING VIRAL GROWTH INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME

#19 | 2024-11-14

US20240374587A1

Human necessities

MEDICINE FOR PREVENTION AND TREATMENT OF DISEASES LINKED TO ANTI-OBESITY ACTIVITY

#20 | 2024-11-07

US20240366622A1

Human necessities

PHARMACEUTICAL PREPARATION EXCELLENT IN LIGHT STABILITY AND DISSOLUTION PROPERTY

#21 | 2024-10-24

US20240352015A1

Chemistry; metallurgy

POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE

#22 | 2024-09-19 ✅ Patent 12,454,533 granted on 2025-10-28

US20240309002A1

Chemistry; metallurgy

FUSED RING DERIVATIVE HAVING MGAT-2 INHIBITORY ACTIVITY

#23 | 2024-08-22

US20240279238A1

Chemistry; metallurgy

POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY

#24 | 2024-08-01 ✅ Patent 12,427,156 granted on 2025-09-30

US20240252505A1

Human necessities

SOLID DOSAGE FORM HAVING EXCELLENT STABILITY

#25 | 2024-07-04

US20240217966A1

Chemistry; metallurgy

PHARMACEUTICAL COMPOSITION CONTAINING GLP-1 RECEPTOR AGONIST HAVING FUSED RING

#26 | 2024-06-13

US20240190975A1

Chemistry; metallurgy

CHIMERIC ANTIGEN RECEPTOR THAT RECOGNIZES CCR8 AS ANTIGEN

#27 | 2024-06-06

US20240182463A1

Chemistry; metallurgy

SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE PRODRUG

#28 | 2024-05-09

US20240148741A1

Human necessities

FORMULATION FOR ORAL ADMINISTRATION, COMPRISING TRIAZINE DERIVATIVE

#29 | 2024-03-14 ✅ Patent 12,637,443 granted on 2026-05-26

US20240083872A1

Chemistry; metallurgy

CYCLIC AMINE DERIVATIVES HAVING SEROTONIN RECEPTOR BINDING ACTIVITY

#30 | 2023-11-30 ✅ Patent 12,528,790 granted on 2026-01-20

US20230382893A1

Chemistry; metallurgy

AMIDE DERIVATIVE HAVING ANTIVIRAL ACTIVITY

#31 | 2023-09-21 ✅ Patent 12,616,389 granted on 2026-05-05

US20230293036A1

Human necessities

ESTIMATION SYSTEM, ESTIMATION METHOD, PROGRAM, ESTIMATION MODEL, BRAIN ACTIVITY TRAINING APPARATUS, BRAIN ACTIVITY TRAINING METHOD, AND BRAIN ACTIVITY TRAINING PROGRAM

#32 | 2023-09-14

US20230287004A1

Chemistry; metallurgy

SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF

#33 | 2023-09-07

US20230278960A1

Chemistry; metallurgy

NOVEL ACRIDINIUM SALT AND METHOD FOR PRODUCING SAME

#34 | 2023-08-24 ✅ Patent 12,400,468 granted on 2025-08-26

US20230267757A1

PROGRAM GENERATION ASSISTING SYSTEM FOR ASSISTING GENERATION OF PROGRAM FOR ANALYZING CLINICAL TRIAL

#35 | 2023-08-17

US20230256092A1

Human necessities

COMBINED USE OF ANTI-CCR8 ANTIBODY AND CHEMOTHERAPEUTIC AGENT

#36 | 2023-07-20 ✅ Patent 12,139,489 granted on 2024-11-12

US20230227454A1

Human necessities

Polycyclic carbamoylpyridone derivative

#37 | 2023-07-06 ✅ Patent 11,814,368 granted on 2023-11-14

US20230212154A1

Chemistry; metallurgy

Triazine derivatives having virus replication inhibitory activity and pharmaceutical composition comprising the same

#38 | 2023-07-06 ✅ Patent 12,521,375 granted on 2026-01-13

US20230210822A1

Human necessities

PHARMACEUTICAL COMPOSITION FOR TREATING FATTY LIVER DISEASE

#39 | 2023-06-22

US20230190174A1

Human necessities

SIGNAL PROCESSING APPARATUS, AND SIGNAL PROCESSING METHOD

#40 | 2023-06-22

US20230190173A1

Human necessities

SIGNAL PROCESSING APPARATUS AND SIGNAL PROCESSING METHOD

#41 | 2023-06-15 ✅ Patent 12,570,627 granted on 2026-03-10

US20230183205A1

Chemistry; metallurgy

PHARMACEUTICAL COMPOSITION IN WHICH PRODUCTION OF IMPURITIES IS SUPPRESSED

#42 | 2023-05-25

US20230158036A1

Human necessities

MEDICAMENT FOR THE TREATMENT OF PAIN

#43 | 2023-05-11 ✅ Patent 12,527,775 granted on 2026-01-20

US20230143664A1

Human necessities

HETEROAROMATIC DERIVATIVES HAVING SEROTONIN RECEPTOR BINDING ACTIVITY

#44 | 2023-04-27 ✅ Patent 12,559,474 granted on 2026-02-24

US20230128162A1

Chemistry; metallurgy

TRIAZINE DERIVATIVES HAVING VIRUS REPLICATION INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

#45 | 2023-04-20 ✅ Patent 12,098,151 granted on 2024-09-24

US20230117695A1

Chemistry; metallurgy

Arenavirus growth inhibitor comprising polycyclic carbamoyl pyridone derivative

#46 | 2023-02-23 ✅ Patent 12,564,595 granted on 2026-03-03

US20230059640A1

Human necessities

PROPHYLACTIC AND THERAPEUTIC PHARMACEUTICAL AGENT FOR HIV INFECTIOUS DISEASES CHARACTERIZED BY COMPRISING COMBINATION OF INTEGRASE INHIBITOR AND ANTI-HIV AGENT

#47 | 2023-02-23 ✅ Patent 12,577,241 granted on 2026-03-17

US20230058677A1

Chemistry; metallurgy

POLYCYCLIC PYRIDOPYRAZINE DERIVATIVE

#48 | 2023-02-09 ✅ Patent 12,612,415 granted on 2026-04-28

US20230040262A1

Chemistry; metallurgy

STEREOSELECTIVE PROCESS FOR PREPARING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES

#49 | 2022-12-15 ✅ Patent 12,312,327 granted on 2025-05-27

US20220396561A1

Chemistry; metallurgy

Crystal of 1,3,5-triazine derivative or solvate thereof and method for producing same

#50 | 2022-12-08

US20220390468A1

HEART FAILURE MARKER

#51 | 2022-11-03 ✅ Patent 12,491,229 granted on 2025-12-09

US20220347259A1

Human necessities

STABILIZED PEPTIDE COMPOSITION

#52 | 2022-10-27

US20220340566A1

Chemistry; metallurgy

BENZYL AMINE-CONTAINING 5,6-HETEROAROMATIC COMPOUNDS USEFUL AGAINST MYCOBACTERIAL INFECTION

#53 | 2022-10-20 ✅ Patent 11,911,394 granted on 2024-02-27

US20220331331A1

Human necessities

Compound and method for the prevention of transmission of influenza virus

#54 | 2022-09-08

US20220281890A1

Chemistry; metallurgy

PHARMACEUTICAL COMPOSITIONS CONTAINING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUG THEREOF

#55 | 2022-08-25 ✅ Patent 12,584,132 granted on 2026-03-24

US20220267778A1

Chemistry; metallurgy

NUCLEIC ACID DRUG TARGETING MURF1

#56 | 2022-08-25 ✅ Patent 12,351,804 granted on 2025-07-08

US20220267771A1

Chemistry; metallurgy

PRODUCTION METHOD FOR BIFURCATED LIPID-LINKED OLIGONUCLEOTIDE, AND INTERMEDIATE

#57 | 2022-08-11 ✅ Patent 11,897,899 granted on 2024-02-13

US20220251113A1

Chemistry; metallurgy

Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect

#58 | 2022-08-11 ✅ Patent 11,807,648 granted on 2023-11-07

US20220251107A1

Chemistry; metallurgy

Process for preparing substituted polycyclic pyridone derivative and crystal thereof

#59 | 2022-07-28

US20220235047A1

Chemistry; metallurgy

A MEDICAMENT FOR TREATING MYCOBACTERIAL INFECTION CHARACTERIZED BY COMBINING A CYTOCHROME bc1 INHIBITOR WITH CLARITHROMYCIN OR AZITHROMYCIN AND CLOFAZIMINE

#60 | 2022-07-07

US20220213121A1

Chemistry; metallurgy

SUBSTITUTED 1,2,3,3a,4,5,7,9,13,13a-DECAHYDROPYRIDO[1',2':4,5]PYRAZINO[1,2-a]PYRROLO[1,2-c]PYRIMIDINES HAVING HIV INTEGRASE INHIBITORY ACTIVITY

#61 | 2022-06-09 ✅ Patent 12,455,270 granted on 2025-10-28

US20220178901A1

MESH FOR DISSOLUTION TEST

#62 | 2022-05-26 ✅ Patent 12,285,526 granted on 2025-04-29

US20220160634A1

Human necessities

Nanoparticle composition with reduced contaminant and production method thereof

#63 | 2022-05-05 ✅ Patent 12,227,509 granted on 2025-02-18

US20220135577A1

Chemistry; metallurgy

Dihydropyrazolopyrazinone derivative having MGAT2 inhibitory activity

#64 | 2022-03-10 ✅ Patent 12,024,519 granted on 2024-07-02

US20220073518A1

Chemistry; metallurgy

Fused ring derivative having MGAT-2 inhibitory activity

#65 | 2022-03-03

US20220064312A1

Chemistry; metallurgy

Novel Anti-CCR8 Antibody

#66 | 2021-12-23 ✅ Patent 11,883,407 granted on 2024-01-30

US20210393640A1

Human necessities

Medicament for the treatment of chronic cough

#67 | 2021-10-14 ✅ Patent 11,685,740 granted on 2023-06-27

US20210317125A1

Chemistry; metallurgy

Bicyclic nitrogen-containing heterocyclic derivatives and pharmaceutical composition comprising the same

#68 | 2021-09-23 ✅ Patent 11,492,352 granted on 2022-11-08

US20210292321A1

Chemistry; metallurgy

Arenavirus growth inhibitor comprising polycyclic carbamoylpyridone derivative

#69 | 2021-09-23

US20210292283A1

Chemistry; metallurgy

6-MEMBERED HETEROCYCLIC DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

#70 | 2021-08-05 ✅ Patent 11,629,154 granted on 2023-04-18

US20210238194A1

Chemistry; metallurgy

Tetrahydropyranooxazine derivatives having selective BACE1 inhibitory activity

#71 | 2021-07-29 ✅ Patent 11,261,198 granted on 2022-03-01

US20210230187A1

Chemistry; metallurgy

Process for preparing substituted polycyclic pyridone derivative and crystal thereof

#72 | 2021-07-22 ✅ Patent 11,643,458 granted on 2023-05-09

US20210221876A1

Chemistry; metallurgy

Monoclonal antibody against Nav1.7

#73 | 2021-06-10 ✅ Patent 11,561,230 granted on 2023-01-24

US20210172964A1

Reference standard for BNP measurement

#74 | 2021-05-27 ✅ Patent 11,453,669 granted on 2022-09-27

US20210155622A1

Chemistry; metallurgy

Polycyclic pyridone derivative

#75 | 2021-05-20 ✅ Patent 12,350,377 granted on 2025-07-08

US20210145753A1

Human necessities

PREPARATION CONTAINING 6,7-UNSATURATED-7-CARBAMOYL MORPHINAN DERIVATIVES

#76 | 2021-04-29 ✅ Patent 11,649,236 granted on 2023-05-16

US20210122751A1

Chemistry; metallurgy

Polycyclic carbamoylpyridone derivative

#77 | 2021-04-22 ✅ Patent 11,932,696 granted on 2024-03-19

US20210115148A1

Chemistry; metallurgy

Method of treating cancer with an anti-CCR8 that binds tumor infiltrating cells

#78 | 2021-04-15 ✅ Patent 11,925,648 granted on 2024-03-12

US20210106589A1

Human necessities

Solid dosage form having excellent stability

#79 | 2021-02-18

US20210047421A1

Chemistry; metallurgy

Pharmaceutical Composition for Cancer Treatment

#80 | 2021-02-18 ✅ Patent 11,447,484 granted on 2022-09-20

US20210047315A1

Chemistry; metallurgy

Cyclic compound having dopamine D3 receptor antagonistic effect

#81 | 2021-02-11 ✅ Patent 11,578,084 granted on 2023-02-14

US20210040117A1

Chemistry; metallurgy

Condensed ring compounds having dopamine D3 receptor antagonistic effect

#82 | 2021-01-14 ✅ Patent 11,345,716 granted on 2022-05-31

US20210009607A1

Chemistry; metallurgy

Nitrogen-containing condensed ring compounds having dopamine D3 antagonistic effect

#83 | 2020-12-10 ✅ Patent 11,638,717 granted on 2023-05-02

US20200384010A1

Human necessities

Complex of nucleic acid medicine and multibranched lipid

#84 | 2020-12-03 ✅ Patent 12,064,438 granted on 2024-08-20

US20200375998A1

Human necessities

Pharmaceutical preparation excellent in light stability and dissolution property

#85 | 2020-11-19 ✅ Patent 11,306,106 granted on 2022-04-19

US20200361958A1

Chemistry; metallurgy

Pharmaceutical compositions containing substituted polycyclic pyridone derivatives and prodrug thereof

#86 | 2020-11-12 ✅ Patent 11,008,320 granted on 2021-05-18

US20200354358A1

Chemistry; metallurgy

Nitrogen-containing heterocycle and carbocycle derivatives having TrkA inhibitory activity

#87 | 2020-10-29 ✅ Patent 11,267,823 granted on 2022-03-08

US20200339598A1

Chemistry; metallurgy

Substituted 1,2,3,3a,4,5,7,9,13,13a-decahydropyrido[1′,2′:4,5]pyrazino[1,2-a]pyrrolo[1,2-c]pyrimidines having HIV integrase inhibitory activity

#88 | 2020-10-29

US20200339565A1

Chemistry; metallurgy

PRODRUG SUBSTITUTED POLYCYCLIC CARBAMOYL PYRIDONE DERIVATIVE

#89 | 2020-10-22 ✅ Patent 11,389,457 granted on 2022-07-19

US20200330473A1

Human necessities

Compound and method for the prevention of transmission of influenza virus

#90 | 2020-09-17 ✅ Patent 11,198,695 granted on 2021-12-14

US20200291025A1

Chemistry; metallurgy

Fused ring derivative having MGAT-2 inhibitory activity

#91 | 2020-09-10

US20200283455A1

Chemistry; metallurgy

SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVES AND PRODRUGS THEREOF

#92 | 2020-08-20 ✅ Patent 11,124,486 granted on 2021-09-21

US20200262796A1

Chemistry; metallurgy

6-membered heterocyclic derivatives and pharmaceutical composition comprising the same

#93 | 2020-08-20 ✅ Patent 11,040,048 granted on 2021-06-22

US20200261481A1

Human necessities

Medicament for treating influenza characterized by combining a Cap-dependent endonuclease inhibitor and an anti-influenza drug

#94 | 2020-08-06 ✅ Patent 11,286,262 granted on 2022-03-29

US20200247818A1

Chemistry; metallurgy

Stereoselective process for preparing substituted polycyclic pyridone derivatives

#95 | 2020-07-16

US20200222463A1

Human necessities

Pharmaceutical Composition for Cancer Treatment

#96 | 2020-05-14 ✅ Patent 11,135,217 granted on 2021-10-05

US20200147074A1

Human necessities

Manufacturing process of formulation having improved content uniformity

#97 | 2020-04-09

US20200109433A1

Chemistry; metallurgy

METHOD FOR EVALUATION OF DRUG EFFICACY OF A MEDICINE HAVING A THERAPEUTIC OR PREVENTIVE EFFECT AGAINST A DISEASE RELATED TO EL ACTIVITY AND A METHOD FOR SCREENING AN INHIBITOR OF EL ACTIVITY

#98 | 2020-03-19 ✅ Patent 10,781,210 granted on 2020-09-22

US20200087302A1

Chemistry; metallurgy

Nitrogen-containing heterocycle and carbocycle derivatives having TrkA inhibitory activity

#99 | 2020-03-05 ✅ Patent 11,136,411 granted on 2021-10-05

US20200071424A1

Chemistry; metallurgy

Method for the treatment or prevention of a disease related to vascular endothelial lipase by administering a humanized monoclonal antibody

#100 | 2020-02-20 ✅ Patent 10,870,661 granted on 2020-12-22

US20200055873A1

Chemistry; metallurgy

Nitrogen-containing tricyclic derivatives having HIV replication inhibitory activity

Also check out Shionogi & Co., Ltd.'s (Osaka, Japan) applicant profile with 156 patent applications submitted.

AssigneeID:

294729 ⎘